Skip to content

Tinnitus Treatment by Structured Cognitive Behavioral Therapy

Randomized Controlled Clinical Trial of Efficacy and Safety of Individual Cognitive Behavioral Therapy (CBT) Within the Setting of the Structured Therapy Program sTCP (Structured Tinnitus Care Program) in Patients With Tinnitus Aurium

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00719940
Acronym
TCP
Enrollment
286
Registered
2008-07-22
Start date
2000-10-31
Completion date
2006-11-30
Last updated
2008-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Keywords

tinnitus, cognitive behavioral therapy, CBT

Brief summary

Test of hypothesis that in contrast to non-treatment tinnitus specific cognitive behavioral therapy intervention procedures that are manualized and structured within the disease management program TCP are effective.

Detailed description

Intervention: Individual application of structured and tinnitus specific cognitive behavioral therapy intervention procedures in the clinical setting of the structured therapy program tinnitus care program (TCP) Duration of intervention per patient: 1-15 treatment sessions plus self treatment up to 16 weeks Control intervention: Waiting group (16 weeks)

Interventions

BEHAVIORALCognitive behavioral therapy

1-15 individual sessions of 50-60 min. to apply 1-15 manualized tinnitus specific cognitive behavioral therapy interventions structured by the tinnitus care disease management program

No intervention

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Persistent and stable tinnitus of more than 11 weeks * Gap between audiometric tinnitus matching and subjective tinnitus loudness rating scale Key

Exclusion criteria

* Psychiatric or neurological comorbidity * Tinnitus as concomitant symptom of an otherwise treatable disease * Drug treatment for tinnitus 24 hrs. prior or during therapy

Design outcomes

Primary

MeasureTime frame
Validated tinnitus questionaire (TF Goebel and Hiller 1992); validated tinnitus change rating scale (TC, Zenner and de Maddalena 2005)Last session

Secondary

MeasureTime frame
Tinnitus loudness (TL), validated 6-point numeric verbal rating scale; tinnitus annoyance (TA), validated 8-point numeric verbal rating scalelast therapy session

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026